So really, for us, a wildcard has really been refining and when this Refining recover back is something approaching a mid cycle. But just to remember how it all builds up on an EBITDA basis, kind of $4 ish,000,000,000 in refining, kind of $2,000,000,000 in midstream, dollars 2,000,000,000 in chemicals and $1,500,000,000 in marketing Specialties pushes you to something like $9,000,000,000 of EBITDA, which translates to $6,000,000,000 to $7,000,000,000 And so I think we're pretty comfortable that we're kind of still in that range. Obviously, we've had some outperformance. I mean, CPChem had a blowout year Last year, all driven by great operations, fundamentally good control of their costs and then super margins. Our Marketing and Specialty businesses, which we typically would say it's a 516 business was $2,000,000,000 And of course, we've been investing in adding retail through our joint ventures.